Login / Signup

PAM-Flexible Genome Editing with an Engineered Chimeric Cas9.

Sabrina KosekiLauren HongVivian YudistyraTeodora StanEmma TysingerRachel SilversteinChristian KrammeNadia AmraniNatasha SavicMartin PacesaTomas C RodriguezManvitha PonnapatiJoseph JacobsonGeorge ChurchRay TruantMartin JinekBenjamin P KleinstiverErik J SontheimerPranam Chatterjee
Published in: Research square (2023)
CRISPR enzymes require a defined protospacer adjacent motif (PAM) flanking a guide RNA-programmed target site, limiting their sequence accessibility for robust genome editing applications. In this study, we recombine the PAM-interacting domain of SpRY, a broad-targeting Cas9 possessing an NRN > NYN PAM preference, with the N-terminus of Sc++, a Cas9 with simultaneously broad, efficient, and accurate NNG editing capabilities, to generate a chimeric enzyme with highly flexible PAM preference: SpRYc. We demonstrate that SpRYc leverages properties of both enzymes to specifically edit diverse NNN PAMs and disease-related loci for potential therapeutic applications. In total, the unique approaches to generate SpRYc, coupled with its robust flexibility, highlight the power of integrative protein design for Cas9 engineering and motivate downstream editing applications that require precise genomic positioning.
Keyphrases
  • genome editing
  • crispr cas
  • cell therapy
  • genome wide
  • cancer therapy
  • drug delivery
  • mesenchymal stem cells
  • protein protein
  • bone marrow
  • genome wide association study
  • solid state